Diminished expression of placental isoferritin p43 component in first trimester abnormal pregnancies

Placenta

Volumn 21, Issue 4, 2000, Pages 408-411

  Jauniaux, E ^a   Maymon, R ^a,b   Greenwold, N ^a   Hustin, J ^c   Moroz, C ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b TEL AVIV UNIVERSITY   (Israel)

^c Institute of Pathology   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFERRITIN; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; IMMUNOHISTOCHEMISTRY; PLACENTA VILLUS; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SYNCYTIOTROPHOBLAST;

EID: 0034040973     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.1999.0491     Document Type: Article

References (18)

1. Elliot DJ, Millar MR, Oghene K, Ross A, Kiesewetter F, Pryor J, McIntyre M, Hargreave TB, Saunders PT, Vogt PH, Chandley AC, Cooke H. Expression of RBM in the nuclei of human germ cells is dependent on a critical region of the Y chromosome long arm. Proc Natl Acad Sci USA. 94:1997;3848-3853.
2. Fisch B, Manor Y, Ovadia J, Moroz C. Placental isoferritin as a marker of early abortion in pregnancies induced by in vitro fertilization. Placenta. 17:1996;247-251.
3. Garty BZ, Kaminsky E, Moroz C. High serum levels of placental isoferritin p43 component in Down syndrome. Children Hospital Quarterly. 9:1997;95-97.
4. Hustin J, Jauniaux E, Schaaps JP. Histological study of the materno-embryonic interface in spontaneous abortion. Placenta. 11:1990;477-486.
5. Jauniaux E, Hustin J. Histological examination of first trimester spontaneous abortions: The impact of materno-embryonic interface features. Histopathology. 21:1992;409-414.
6. Jokhi PP, King A, Loke YW. Cytokine production and cytokine receptor expression by cells of the human first trimester placental-uterine interface. Cytokine. 9:1997;126-137.
7. Kajii T, Omaha K. Androgenic origin of hydatidiform mole. Nature. 268:1977;633-634.
8. Khong TY, Liddell HS, Robertson WB. Defective haemochorial placentation as a cause of miscarriage. A preliminary study. Br J Obstet Gynaecol. 94:1987;649-655.
9. Maymon R, Weinraub Z, Bukovsky I, Moroz C. Placental isoferritin levels during first trimester of normal and complete molar gestations. Placenta. 16:1995;455-460.
10. Maymon R, Moroz Z. Placental isoferritin: a new biomarker from conception to delivery. Br J Obstet Gynaecol. 103:1996;301-305.
11. Moroz C, Kupfer B, Twig S, Parhami-Seren B. Preparation and characterization of mononuclear antibodies specific to placental ferritin. Clin Chim Acta. 114:1985;111-118.
12. Moroz C, Bessler H, Lurie Y, Shaklai M. A new monoclonal antibody enzymoassay for the specific measurement of placenta-like ferritin in hematologic malignancies. Exp Hematol. 15:1987a;258-262.
13. Moroz C, Bessler H, Sirota L, Dulitzky F, Djaldetti M. Difference in the placental ferritin levels measured by a specific monoclonal antibody enzymoassay in preterm and term delivery. Clin Exp Immunol. 69:1987b;702-706.
14. Moroz C, Bessler H. Ferritin as a marker of malignancy. de Sousa M, Brock JH. Iron in Immunity, Cancer and Inflammation. 1989a;283-299 John Wiley and Sons Ltd, New York.
15. Moroz C, Misrock S, Siegal FP. Isoferritins in HIV infection: relation to clinical stage CD8 Lymphocyte binding and the pathogenesis of AIDS. AIDS. 3:1989b;11-16.
16. Moroz C, Shterman N, Kupfer B, Ginzburg I. T-cell mitogenesis stimulates the synthesis of a mRNA species coding for a 43-kDa peptide reactive with CM-H-9, a monoclonal antibody specific for placental isoferritin. Proc Natl Acad Sci USA. 86:1989c;3282-3285.
17. Robinson JS, Hartwich KM, Walker SK, Erwich JJ, Owens JA. Early influences on embryonic and placental growth. Acta Paediatr. S423:1997;159-163.
18. Sirota L, Kupfer B, Moroz C. Placental isoferritin as a physiological downregulator of cellular immunoreactivity during pregnancy. Clin Expl Immunol. 77:1989;255-262.